Retinoid suppression of ventricular muscle cell hypertrophy
US5968981A · kind A · utility
5Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 1998 |
| Grant date | Oct 19, 1999 |
| Priority date | — |
| Expiry date | Mar 10, 2018 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/9453
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method of suppressing ventricular muscle cell hypertrophy induced by an .alpha..sub.1 -adrenergic agonist or endothelin, by providing an effective amount of a retinoic acid compound. Also provided are methods for identifying compounds which suppress ventricular muscle cell hypertrophy, compounds which inhibit the retinoic acid suppression of ventricular muscle cell hypertrophy, and therapeutic methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.